Integral Diagnostics Limited (IDX.AX)

AUD 2.26

(-0.44%)

Long Term Debt Summary of Integral Diagnostics Limited

Integral Diagnostics Limited's latest annual long term debt in 2024 was 219.75 Million AUD , down -0.63% from previous year.
Integral Diagnostics Limited's latest quarterly long term debt in 2024 FY was 219.75 Million AUD , up 0.37% from previous quarter.
Integral Diagnostics Limited reported annual long term debt of 218.95 Million AUD in 2023, up 2.77% from previous year.
Integral Diagnostics Limited reported annual long term debt of 213.05 Million AUD in 2022, up 13.35% from previous year.
Integral Diagnostics Limited reported quarterly long term debt of 220.28 Million AUD for 2024 Q2, down -0.39% from previous quarter.
Integral Diagnostics Limited reported quarterly long term debt of 219.75 Million AUD for 2024 Q4, down -0.24% from previous quarter.

Annual Long Term Debt Chart of Integral Diagnostics Limited (2024 - 2013)

Historical Annual Long Term Debt of Integral Diagnostics Limited (2024 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2024	219.75 Million AUD	-0.63%
2023	218.95 Million AUD	2.77%
2022	213.05 Million AUD	13.35%
2021	187.97 Million AUD	19.72%
2020	157 Million AUD	27.77%
2019	122.88 Million AUD	180.09%
2018	43.87 Million AUD	0.28%
2017	43.75 Million AUD	7.39%
2016	40.73 Million AUD	-23.71%
2015	53.4 Million AUD	1235.0%
2014	4 Million AUD	0.0%
2013	- AUD	0.0%

Year	Long Term Debt	Long Term Debt Growth
2024 FY	219.75 Million AUD	0.37%
2024 Q2	220.28 Million AUD	-0.39%
2024 Q4	219.75 Million AUD	-0.24%
2023 Q2	217.11 Million AUD	1.9%
2023 FY	218.95 Million AUD	2.77%
2023 Q4	218.95 Million AUD	0.85%
2022 FY	213.05 Million AUD	13.35%
2022 Q2	215.11 Million AUD	14.44%
2022 Q4	213.05 Million AUD	-0.96%
2021 Q2	190.22 Million AUD	21.16%
2021 Q4	187.97 Million AUD	-1.18%
2021 FY	187.97 Million AUD	19.72%
2020 Q4	157 Million AUD	13.54%
2020 FY	157 Million AUD	27.77%
2020 Q2	138.27 Million AUD	12.53%
2019 Q2	129 Million AUD	194.04%
2019 Q4	122.88 Million AUD	-4.74%
2019 FY	122.88 Million AUD	180.09%
2018 Q2	56.54 Million AUD	29.25%
2018 FY	43.87 Million AUD	0.28%
2018 Q4	43.87 Million AUD	-22.41%
2017 Q2	63.23 Million AUD	55.22%
2017 Q4	43.75 Million AUD	-30.81%
2017 FY	43.75 Million AUD	7.39%
2016 Q4	40.73 Million AUD	-29.57%
2016 Q2	57.84 Million AUD	-16.4%
2016 FY	40.73 Million AUD	-23.71%
2015 Q4	69.19 Million AUD	0.0%
2015 FY	53.4 Million AUD	1235.0%
2014 FY	4 Million AUD	0.0%
2013 FY	- AUD	0.0%

Peer Long Term Debt Comparison of Integral Diagnostics Limited

Name	Long Term Debt	Long Term Debt Difference
Australian Clinical Labs Limited	55.06 Million AUD	-299.092%
BCAL Diagnostics Limited	400.22 Thousand AUD	-54808.663%
Genetic Signatures Limited	- AUD	-Infinity%
Genetic Technologies Limited	- AUD	-Infinity%
Healius Limited	420.8 Million AUD	47.777%
Imagion Biosystems Limited	750 Thousand AUD	-29200.8%
INOVIQ Ltd	- AUD	-Infinity%
Microba Life Sciences Limited	- AUD	-Infinity%
Monash IVF Group Limited	59.56 Million AUD	-268.935%
Rhythm Biosciences Limited	- AUD	-Infinity%
Sonic Healthcare Limited	2.69 Billion AUD	91.832%